The TGF-β/SMAD pathway acts as a tumor suppressor in early stages and later facilitates transformation through mechanisms such as the epithelial–mesenchymal transition (EMT), which endows cells with stem-like features [40]. The gene discussed is TGFB1; the disease is neoplasm.